858 THERAPEUTICS ANNOUNCES FDA FAST TRACK DESIGNATION FOR PARG INHIBITOR ETX-19477 FOR THE TREATMENT OF PATIENTS WITH BRCA-MUTATED, HR+/HER2- UNRESECTABLE OR METASTATIC BREAST CANCER

Reuters · 2d ago

Please log in to view news